Use of Hypolipidemic Drugs and the Risk of Second Primary Malignancy in Colorectal Cancer Patients.
Halámková J, Bohovicová L, Pehalová L, Goněc R, Staněk T, Kazda T, Mouková L, Krákorová DA, Kozáková Š, Svoboda M, Demlová R, Kiss I.
Halámková J, et al. Among authors: moukova l.
Cancers (Basel). 2022 Mar 27;14(7):1699. doi: 10.3390/cancers14071699.
Cancers (Basel). 2022.
PMID: 35406471
Free PMC article.